FDA Warning Letter — University of Miami Infertility Center
The FDA took a Warning Letter action against University of Miami Infertility Center on December 3, 2018 (Miami, FL). The action was issued by CBER and concerns biologics products. This facility has 5 or more recent FDA inspections on record.
Action Details
- Facility
- University of Miami Infertility Center
- Date
- December 3, 2018
- Fiscal Year
- 2019
- Product Type
- Biologics
- Center
- CBER
- Location
- Miami, FL (United States)